PerkinElmer buys Edico Genome processor; IMS acquires real-world evidence company;

> Edico Genome sold a Dragen Bio-IT processor to PerkinElmer ($PKI). Release

> IMS Health bought Dataline Software to expand its real-world evidence offering. Item

> A comparison of Apple Watch to a validated heart monitor suggests the wearables' data is more accurate than early reviews reported. Article

> Apple ($AAPL) provided an update on the progress of the first batch of ResearchKit apps. More

> Johnson & Johnson ($JNJ) recruited an expert panel to insulate it from social media-driven campaigns for access to experimental medicines. Piece

> Genomics England's general counsel outlined the legal issues facing the organization. Interview